Patent AnalyticsExaminers
Rankings

Company or institution

LDN Pharma Limited

20 applicationsfiled 2018 to 2024

Allowance rate
73%
−3 pts vs the USPTO range 43% to 90%
Rejections before allowance
2.6
+1.0 vs the USPTO
Months to first action
24.5 mo
+5.9 vs the USPTO
Needed an RCE
67%
+40 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

A61K Medical preparations15 apps
G01N Investigating or analysing materials4 apps
A61P Therapeutic activity of compounds1 apps

Art units

16288 apps
16293 apps
16252 apps
16241 apps
OPAP1 apps
16361 apps

Who represents them

Law firms and agents on their applications

Bars show the share of decided applications that were allowed.

Unlock the firms on their applicationsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

ApplicationTitleFiledStatusRejectionsRCEsTo 1st action
18916423PRIMING OF CANCER CELLS WITH LOW DOSE NALTREXONE2024-10-15Pending00n/a
18573359NALTREXONE FOR IMPROVING THE EFFECTIVENESS OF 5-HT RECEPTOR SUBTYPE 2A, 2B or 2C AG…2023-12-21Pending2026.6 mo
18573362TREATMENT FOR AUTOIMMUNE DISEASES2023-12-21Pending1026.2 mo
15184005Method and apparatus for adaptive signal processing2012-01-10Allowed1012.0 mo
15771340Composition and method for controlled release2015-02-11Abandoned4123.0 mo
15505637Distributed ledger transaction verification2018-03-12Allowed3020.0 mo
15927737Thermal management of battery assemblies2021-04-13Pending2117.0 mo
15286699Machine learning model for anomaly detection2012-05-14Allowed1014.0 mo
15754783Wireless power transfer coil arrangement2015-06-15Abandoned4125.0 mo
15835680Catalyst for selective hydrogenation2018-07-16Allowed3022.0 mo
Unlock all 20 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in